Michael Barbella, Managing Editor02.04.21
Omnia Medical has welcomed two new members to its executive team.
The spine company has hired Jennifer Martin as president of the firm's new Interventional Pain Therapies Division, and Dan Rogers as its vice president of sales. The new division, according to Omnia Medical, is intended to help pain management specialists provide better treatments to patients suffering from debilitating sacroiliac (SI) joint pain.
"I am incredibly excited to join Omnia Medical. The company has a unique opportunity to accelerate an already impressive growth trajectory and become the posterior SI joint fusion system of choice for interventional pain management physicians and spine surgeons. I look forward to working with our Omnia Medical team and applying my experience and deep understanding of market development and growth for medical device companies," Martin said.
Martin brings more than 15 years of experience in product training and market development to her new position. Most recently she served as senior director of Customer Engagement at Boston Scientific Corp. Prior to her time at Boston Scientific, she served as CEO of Next Level Interactive, senior director of Field and Physician Development at St. Jude Medical Inc., and vice president of Global Sales Training at KCI Medical.
Martin will be working closely with Rogers, who most recently served as regional sales director at Boston Scientific and Vertiflex. With more than a decade of experience, Rogers will join Thomas Batton and Sean Herd in working closely with Martin to grow and further advance technologies within the Interventional Pain Therapies division.
This new division will provide a strong collaboration between spine surgeons and pain management specialists when diagnosing accurate patient pathology as spine related or SI joint dysfunction. This collaboration will further provide an opportunity for pain management specialists to integrate SI joint fusion technologies in their treatment algorithm for patients.
The launch of the new division comes at a critical time when providers are increasingly focused on delivering a more comprehensive range of therapies. Omnia Medical is combining its research and development expertise with manufacturing experience to provide minimally invasive solutions tailored specifically to pain management specialists.
The spine company has hired Jennifer Martin as president of the firm's new Interventional Pain Therapies Division, and Dan Rogers as its vice president of sales. The new division, according to Omnia Medical, is intended to help pain management specialists provide better treatments to patients suffering from debilitating sacroiliac (SI) joint pain.
"I am incredibly excited to join Omnia Medical. The company has a unique opportunity to accelerate an already impressive growth trajectory and become the posterior SI joint fusion system of choice for interventional pain management physicians and spine surgeons. I look forward to working with our Omnia Medical team and applying my experience and deep understanding of market development and growth for medical device companies," Martin said.
Martin brings more than 15 years of experience in product training and market development to her new position. Most recently she served as senior director of Customer Engagement at Boston Scientific Corp. Prior to her time at Boston Scientific, she served as CEO of Next Level Interactive, senior director of Field and Physician Development at St. Jude Medical Inc., and vice president of Global Sales Training at KCI Medical.
Martin will be working closely with Rogers, who most recently served as regional sales director at Boston Scientific and Vertiflex. With more than a decade of experience, Rogers will join Thomas Batton and Sean Herd in working closely with Martin to grow and further advance technologies within the Interventional Pain Therapies division.
This new division will provide a strong collaboration between spine surgeons and pain management specialists when diagnosing accurate patient pathology as spine related or SI joint dysfunction. This collaboration will further provide an opportunity for pain management specialists to integrate SI joint fusion technologies in their treatment algorithm for patients.
The launch of the new division comes at a critical time when providers are increasingly focused on delivering a more comprehensive range of therapies. Omnia Medical is combining its research and development expertise with manufacturing experience to provide minimally invasive solutions tailored specifically to pain management specialists.